Suchergebnisse - "Visanji, Naomi P"

PubPharm (129)

21

Alpha-synuclein seeding shows a wide heterogeneity in multiple system atrophy

enthalten in: Translational neurodegeneration | 2022

von Martinez-Valbuena, I. | Visanji, N. | Kim, A. | +9

22

Patterns of Mixed Pathologies in Down Syndrome

enthalten in: Journal of Alzheimer's disease : JAD | 2022

von Ichimata, S. | Yoshida, K. | Visanji, N. | +3

23

Axial Impairment Following Deep Brain Stimulation in Parkinson's Disease : A Surgicogenomic Approach

enthalten in: Journal of Parkinson's disease | 2022

von Visanji, N. | Ghani, M. | Yu, E. | +21

24

Alpha-Synuclein Targeting Therapeutics for Parkinson's Disease and Related Synucleinopathies

enthalten in: Frontiers in neurology | 2022

von Menon, S. | Armstrong, S. | Hamzeh, A. | +3

25

Combining Skin α‐Synuclein Real‐Time Quaking‐Induced Conversion and Circulating Neurofilament Light Chain to Distinguish Multiple System Atrophy and Parkinson's Disease

enthalten in: Movement Disorders | 2022

von Martinez‐Valbuena, I. | Visanji, N. | Olszewska, D. | +7

26

Epigenetic Clock Acceleration Is Linked to Age at Onset of Parkinson's Disease

enthalten in: Movement Disorders | 2022

von Tang, X. | Gonzalez‐Latapi, P. | Marras, C. | +6

27

Short-term deceleration capacity of heart rate : a sensitive marker of cardiac autonomic dysfunction in idiopathic Parkinson's disease

enthalten in: Clinical autonomic research : official journal of the Clinical Autonomic Research Society | 2021

von Carricarte Naranjo, C. | Marras, C. | Visanji, N. | +9

28

Small molecule inhibitors of α-synuclein oligomers identified by targeting early dopamine-mediated motor impairment in C. elegans

enthalten in: Molecular neurodegeneration | 2021

von Chen, K. | Menezes, K. | Rodgers, J. | +23

29

Small molecule inhibitors of α-synuclein oligomers identified by targeting early dopamine-mediated motor impairment in C. elegans

enthalten in: Molecular neurodegeneration | 2021

von Chen, K. | Menezes, K. | Rodgers, J. | +23

30

Small molecule inhibitors of α-synuclein oligomers identified by targeting early dopamine-mediated motor impairment in C. elegans

enthalten in: Molecular neurodegeneration | 2021

von Chen, K. | Menezes, K. | Rodgers, J. | +23